Key Takeaways From Gritstone Bio Analyst Ratings
Key Takeaways From Gritstone Bio Analyst Ratings
Gritstone Bio分析师评级要点
The analysis of...Across the recent three months, 4 analysts have shared their insights on Gritstone Bio (NASDAQ:GRTS), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月里，4位分析师就纳斯达克上的Gritstone Bio（纳斯达克：GRTS）发表了他们的见解，从看好到看淡等各种不同观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $3.38, a high estimate of $5.00, and a low estimate of $0.50. Observing a downward trend, the current average is 20.47% lower than the prior average price target of $4.25.
分析师通过对12个月价格目标的评估提供了更深入的见解，显示出平均目标为$3.38，最高估值为$5.00，最低估值为$0.50。观察到一种下降趋势，当前的平均目标比之前的$4.25的平均价格目标低了20.47%。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The analysis of...
对最近...
登录免费看全文
登录/注册